Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
Department of Pharmacy and Biotechnology, Faculty of Medicine and Health Sciences, University of Palestine, Gaza, Palestine.
Curr Mol Pharmacol. 2023;16(1):43-59. doi: 10.2174/1874467215666220222105004.
Dysbiosis has been linked to various diseases ranging from cardiovascular, neurologic, gastrointestinal, respiratory, and metabolic illnesses to cancer. Restoring of gut microbiota balance represents an outstanding clinical target for the management of various multidrug-resistant diseases. Preservation of gut microbial diversity and composition could also improve stem cell therapy which now has diverse clinical applications in the field of regenerative medicine. Gut microbiota modulation and stem cell therapy may be considered a highly promising field that could add up towards the improvement of different diseases, increasing the outcome and efficacy of each other through mutual interplay or interaction between both therapies. Importantly, more investigations are required to reveal the cross-talk between microbiota modulation and stem cell therapy to pave the way for the development of new therapies with enhanced therapeutic outcomes. This review provides an overview of dysbiosis in various diseases and their management. It also discusses microbiota modulation via antibiotics, probiotics, prebiotics, and fecal microbiota transplant to introduce the concept of dysbiosis correction for the management of various diseases. Furthermore, we demonstrate the beneficial interactions between microbiota modulation and stem cell therapy as a way for the development of new therapies in addition to limitations and future challenges regarding the applications of these therapies.
肠道菌群失调与各种疾病有关,范围从心血管、神经、胃肠道、呼吸和代谢疾病到癌症。恢复肠道微生物群落平衡是管理各种多药耐药疾病的一个突出的临床目标。保持肠道微生物多样性和组成也可以改善干细胞治疗,目前干细胞治疗在再生医学领域有多种临床应用。肠道菌群调节和干细胞治疗可以被认为是一个非常有前途的领域,可以通过两种治疗方法的相互作用或相互影响,在改善不同疾病方面发挥作用,提高彼此的疗效。重要的是,需要更多的研究来揭示菌群调节和干细胞治疗之间的相互作用,为开发具有增强治疗效果的新疗法铺平道路。本综述概述了各种疾病中的肠道菌群失调及其管理。它还讨论了通过抗生素、益生菌、益生元和粪便微生物移植来调节肠道菌群,以介绍纠正肠道菌群失调的概念,从而管理各种疾病。此外,我们展示了肠道菌群调节和干细胞治疗之间的有益相互作用,这是开发新疗法的一种方式,同时还讨论了这些疗法的应用的局限性和未来挑战。